Partially randomised, patient preference trials for inflammatory bowel disease. Noor NM, Siegel C. Lancet Gastroenterol Hepatol 2022;7:981-983.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Noor NM, Siegel C. Partially randomised, patient preference trials for inflammatory bowel disease. Lancet Gastroenterol Hepatol 2022;7:981-983.
PMID: 36208633